Final Program Introduction of CVRFBayer Korea researches, develops, manufactures and markets innovative products for the prevention, diagnosis and treatment of diseases. The company plays an important role in improving the health of people and animals. This subgroup comprises Pharmaceuticals, Madical Care.
Booth No. B39
| Lunchtime Activities | |
| Addressing Unmet Needs in the Treatment for CVD High-Risk Patients | |
| Organized by CVRF and Supported by Educational Grant from Bayer Korea | |
|
Sunday, April 29 12:45 PM - 1:45 PM Room 1A, Level 3 |
|
| Moderator(s): Tae Hoon Ahn, Seung-Ho Hur | |
| Panelist(s): Yun-Kyeong Cho, Jae Sik Jang, Jong-Young Lee, Jung-Won Suh, Hoyoun Won | |
| 12:45 PM | Recent Update of Antithrombotic Treatment for NVAF Patients Undergoing PCI
Lecturer : Pil Ki Min
|
| 1:05 PM | Identifying Patients with CAD or PAD at Highest Risk of Cardiovascular Events
Lecturer : Chang-Hwan Yoon
|
| 1:25 PM | Panel Discussion |
